WallStreetZenWallStreetZen

NASDAQ: CYTK
Cytokinetics Inc Stock Forecast, Predictions & Price Target

Analyst price target for CYTK

Based on 9 analysts offering 12 month price targets for Cytokinetics Inc.
Min Forecast
$49.00+75.75%
Avg Forecast
$58.33+109.23%
Max Forecast
$71.00+154.66%

Should I buy or sell CYTK stock?

Based on 9 analysts offering ratings for Cytokinetics Inc.
Strong Buy
Strong Buy
4 analysts 44.44%
Buy
5 analysts 55.56%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CYTK stock forecasts and price targets.

CYTK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Cantor Fitzgerald
Top 6%
95
Strong BuyReiterates$59.00+111.62%2023-08-22
SVB Leerink
Bottom 5%
5
BuyInitiates Coverage On$58.00+108.03%2023-08-15
Needham
Bottom 2%
2
BuyReiterates$60.00+115.21%2023-08-04
Morgan Stanley
Bottom 19%
19
Strong BuyReiterates$60.00+115.21%2023-08-04
HC Wainwright & Co.
Bottom 1%
1
BuyReiterates$49.00+75.75%2023-08-04
JMP Securities
Bottom 4%
4
BuyReiterates$71.00+154.66%2023-05-22
Oppenheimer
Bottom 13%
13
BuyReiterates$54.00+93.69%2023-05-16
Goldman Sachs
Top 2%
99
Strong BuyMaintains$53.00+90.10%2023-05-05
UBS
Bottom 7%
7
Strong BuyMaintains$61.00+118.79%2023-04-03

1 of 1

Forecast return on equity

Is CYTK forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is CYTK forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.05%

CYTK revenue growth forecast

How is CYTK forecast to perform vs Biotechnology companies and vs the US market?
Company
225.18%
Industry
34.31%
Market
8.24%
CYTK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CYTK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CYTK vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CYTK$27.88$58.33+109.23%Strong Buy
CORT$26.29$30.17+14.75%Buy
MDGL$143.36$279.00+94.61%Buy
DNLI$19.79$65.00+228.45%Strong Buy
NUVL$45.81$52.80+15.26%Strong Buy

Cytokinetics Stock Forecast FAQ

Is Cytokinetics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: CYTK) stock is to Strong Buy CYTK stock.

Out of 9 analysts, 4 (44.44%) are recommending CYTK as a Strong Buy, 5 (55.56%) are recommending CYTK as a Buy, 0 (0%) are recommending CYTK as a Hold, 0 (0%) are recommending CYTK as a Sell, and 0 (0%) are recommending CYTK as a Strong Sell.

If you're new to stock investing, here's how to buy Cytokinetics stock.

What is CYTK's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: CYTK) forecast ROE is N/A, which is considered weak.

What is CYTK's Price Target?

According to 9 Wall Street analysts that have issued a 1 year CYTK price target, the average CYTK price target is $58.33, with the highest CYTK stock price forecast at $71.00 and the lowest CYTK stock price forecast at $49.00.

On average, Wall Street analysts predict that Cytokinetics's share price could reach $58.33 by Aug 22, 2024. The average Cytokinetics stock price prediction forecasts a potential upside of 109.23% from the current CYTK share price of $27.88.

What is CYTK's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: CYTK) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.05%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.